Literature DB >> 9602271

Treatment of post-transplant lymphoproliferative disease (PTLD) following solid organ transplantation with low-dose chemotherapy.

T G Gross, S H Hinrichs, J Winner, T C Greiner, S S Kaufman, P H Sammut, A N Langnas.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9602271     DOI： 10.1023/a:1008263226895

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Treatment of solid organ transplant recipients with autologous Epstein Barr virus-specific cytotoxic T lymphocytes (CTLs).

Authors:  Barbara Savoldo; John A Goss; Markus M Hammer; Lan Zhang; Teresita Lopez; Adrian P Gee; Yu-Feng Lin; Ruben E Quiros-Tejeira; Petra Reinke; Stephan Schubert; Stephen Gottschalk; Milton J Finegold; Malcolm K Brenner; Cliona M Rooney; Helen E Heslop
Journal:  Blood       Date:  2006-07-11       Impact factor: 22.113

Review 2.  Current developments in pediatric liver transplantation.

Authors:  Christina Hackl; Hans J Schlitt; Michael Melter; Birgit Knoppke; Martin Loss
Journal:  World J Hepatol       Date:  2015-06-18

Review 3.  Organ transplant-related lymphoma.

Authors:  L J Swinnen
Journal:  Curr Treat Options Oncol       Date:  2001-08

4.  Current status of liver transplantation.

Authors:  Deirdre Kelly; Anupam Sibal
Journal:  Indian J Pediatr       Date:  2003-09       Impact factor: 1.967

5.  Remission of late-onset post-heart transplantation lymphoproliferative disorder following treatment with rituximab and modified mini-CHOP chemotherapy: A case report.

Authors:  Qiang Huang; Tianxin Yang; Xing Jin; Xuming Ni; Haiyan Qi; Zhikun Yan
Journal:  Exp Ther Med       Date:  2016-05-05       Impact factor: 2.447
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.